Capabilities
What we can run, where we run it, and who we can reach.
Therapeutic areas
The specialties IPES runs clinical studies in — the same list published on the Portuguese site.
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hepatology
Infectious diseases
Oncology
Ophthalmology
Orthopaedics
Paediatrics
Pulmonology
Rheumatology
Site and infrastructure
Everything a monitoring visit will ask about.
.jpeg&w=3840&q=75)
Hospital-based facility
Dedicated research space on the 5th floor of Hospital ProntoCordis, with imaging, laboratory and emergency support in the same building.
.jpeg&w=3840&q=75)
Investigational product handling
Temperature-controlled storage with continuous monitoring, controlled access and full accountability records.
.jpeg&w=3840&q=75)
Source data and participant records
Participants are managed in our own system, with an auditable trail of every access, change and export, under Brazil’s LGPD.
.jpeg&w=3840&q=75)
Trained study team
Investigators and coordinators trained in ICH-GCP, supported by the institute’s own education programme.
Regulatory framework
Brazil has its own approval path, and it is the step that most often surprises first-time sponsors.
CEP / CONEP
Ethics review runs through a local research ethics committee (CEP) and, for certain study types, the national commission (CONEP). We manage submission and follow-up.
ANVISA
Brazil’s health regulatory agency authorises clinical trials and the import of investigational product. Timelines here should be built into your start-up plan.
LGPD
Brazil’s data protection law treats health data as sensitive. Our participant records, consent process and data retention are built around it.
Send us a synopsis
The fastest way to find out whether we fit is to let us look at the protocol. We will give you an honest feasibility read, including where we think enrolment would be difficult.